Form 6-K Intec Pharma Ltd. For: Oct 07

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT of 1934

 

For the month of October 2016

 

001-37521

(Commission File Number)

 

INTEC PHARMA LTD.

(Translation of registrant’s name into English)

 

12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel

(+972) (2) 586-4657

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover

Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________

 

Intec Pharma Ltd. (the “Company”) hereby announces that the board of directors of the Company resolved to cancel the call of the special general meeting of shareholders. The meeting was scheduled to be held on October 18, 2016. 

 

This report on Form 6-K is hereby incorporated by reference into the Company’s registration statements on Form S-8 (Files No. 333-209700 and No. 333-212801).

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	INTEC PHARMA LTD.
	By:	/s/ Zeev Weiss
		Name: Zeev Weiss
		Title: Chief Executive Officer
Date: October 7, 2016

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Progress on ABN AMRO share buyback programme 12 April – 18 April 2024
• Empowering Moms: Momcozy Unveils Its Perfect Wearable Pumping Solution for 2024
• Groupama Assurances Mutuelles calls for redemption of its undated subordinated bond (FR0011896513)